Hetero launches generic lapatinib in India

14:17 EST 11 Jan 2019 | PharmaBiz

Hetero, one of India's leading generic pharmaceutical companies and world's largest producer of anti─retroviral drugs, announces the launch of generic version of lapatinib (250 mg) tablets in India. The product is

Original Article: Hetero launches generic lapatinib in India


More From BioPortfolio on "Hetero launches generic lapatinib in India"

Quick Search


Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...